NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
Quick Stats
Jan 30, 202654.0
AI Score
HOLD1.03
Volume Ratio
Mar 05, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
NXTC Stock Summary
Last updated Jan 30, 2026
NXTC is currently trading at $10.85, positioned above its 200-day moving average of $6.83, indicating a long-term uptrend. The stock has a 52-week range of $0.39 to $15.7399.
Technical Analysis: The 50-day moving average stands at $12.28, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.227, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.092, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NXTC at 54.0/100 with a HOLD recommendation.
NXTC (NextCure, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.227 |
| CMF (20) | -0.092 |
| ROC (10) | -15.695 |
| ADX (14) | 29.723 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.382 |
| AROONOSC (14) | -85.714 |
| WILLAMS %R (14) | -88.315 |
| MFI (14) | 36.066 |
NXTC Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NXTC Price vs Max Options Open Interest
NXTC Max Change In Options Open Interest
NXTC Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NXTC Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NXTC Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NXTC Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NextCure, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NXTC Moving Averages Analysis
NextCure, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
NXTC (NextCure, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 11.92 |
| 20 | 12.63 |
| 30 | 12.56 |
| 50 | 12.28 |
| 100 | 10.06 |
| 200 | 6.83 |
NXTC Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 38.0 million |
| Earnings/Share ($) | -23.81 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -13.7267 |
| EPS Estimate Next Year ($) | -8.2233 |
| WallStreet Target Price ($) | 17.6667 |
| Most Recent Quarter |